Does LORAZEPAM Cause Gait inability? 88 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Gait inability have been filed in association with LORAZEPAM (Lorazepam). This represents 0.3% of all adverse event reports for LORAZEPAM.
88
Reports of Gait inability with LORAZEPAM
0.3%
of all LORAZEPAM reports
37
Deaths
50
Hospitalizations
How Dangerous Is Gait inability From LORAZEPAM?
Of the 88 reports, 37 (42.0%) resulted in death, 50 (56.8%) required hospitalization, and 32 (36.4%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which LORAZEPAM Alternatives Have Lower Gait inability Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN